首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1585196

全球關節疼痛注射市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Joint Pain Injections Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年11月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球關節疼痛注射市場需求預計將從 2023 年的 61.2 億美元達到近 127 億美元的市場規模，2024-2032 年研究期間複合年成長率為 8.44%。

關節疼痛注射是一種微創治療方法，用於緩解關節疼痛和炎症，這些疼痛和發炎通常由關節炎、損傷或退化性疾病引起。這些注射劑可能含有皮質類固醇、透明質酸或再生醫學成分，如富含血小板的血漿 (PRP)。皮質類固醇注射可減輕炎症，而透明質酸可改善關節潤滑和緩衝作用。 PRP 和其他再生療法可促進自然癒合和組織修復。這些注射直接注射到受影響的關節中，可以提供有針對性的緩解，並可以延遲手術的需要。它們廣泛用於骨科，以增強慢性關節疼痛患者的活動能力並改善生活品質。

市場動態

肌肉骨骼疾病的日益普及以及更容易出現關節相關問題的人口老化推動了關節疼痛注射市場的發展。骨關節炎和類風濕關節炎病例不斷增加，增加了對關節疼痛注射等有效疼痛管理解決方案的需求。對微創治療的日益偏好是另一個關鍵因素，因為關節疼痛注射無需手術即可緩解。注射療法的進步，例如富血小板血漿 (PRP) 和透明質酸注射液的開發，正在增強關節疼痛注射的功效和安全性。運動傷害也促進了市場的成長，運動員和活躍的個人尋求快速有效的疼痛緩解。人們對關節健康的認知不斷提高，先進的醫療設施也越來越多，這正在支持關節止痛注射劑的採用。此外，旨在創造更持久、更有針對性的注射劑的研發工作正在推動該領域的創新。關節止痛注射的保險範圍和報銷政策也對市場產生正面影響。非侵入性治療的日益普及以及與重複注射相關的安全問題可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球關節疼痛注射市場的每個細分市場進行了包容性評估。關節疼痛注射產業的成長和趨勢為本研究提供了整體方法。

市場區隔

關節疼痛注射市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按接頭類型

膝蓋和腳踝
髖關節
肩部和肘部
脊椎小關節
其他

按注射類型

皮質類固醇注射劑
玻尿酸注射液
其他

按配銷通路

醫院藥房
零售藥局
網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲關節疼痛注射市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。關節疼痛注射市場的主要參與者包括艾爾建公司（Allergan Plc）、輝瑞公司（Pfizer Inc.）、賽諾菲（Sanofi）、Anika Therapeutics Inc.、Ferring BV、Bioventus、Flexion Therapeutics Inc.、Zimmer Biomet Holdings Inc.、Seikagaku Corporation、Chugai Pharmaceutical Co. Ltd.。新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：關節止痛注射公司的競爭格局

關節止痛注射劑市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Allergan Plc

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Anika Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Ferring BV

公司概況
公司收入
產品
最新動態

Bioventus

公司概況
公司收入
產品
最新動態

Flexion Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Zimmer Biomet Holdings Inc.

公司概況
公司收入
產品
最新動態

Seikagaku Corporation

公司概況
公司收入
產品
最新動態

Chugai Pharmaceutical Co. Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11210961

The global demand for Joint Pain Injections Market is presumed to reach the market size of nearly USD 12.7 Billion by 2032 from USD 6.12 Billion in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Joint Pain Injections are minimally invasive treatments used to relieve pain and inflammation in joints, commonly caused by arthritis, injuries, or degenerative conditions. These injections may contain corticosteroids, hyaluronic acid, or regenerative medicine components like platelet-rich plasma (PRP). Corticosteroid injections reduce inflammation, while hyaluronic acid improves joint lubrication and cushioning. PRP and other regenerative therapies promote natural healing and tissue repair. Administered directly into the affected joint, these injections provide targeted relief and can delay the need for surgery. They are widely used in orthopedics to enhance mobility and improve the quality of life for patients with chronic joint pain.

Market Dynamics

The Joint Pain Injections market is being driven by the increasing prevalence of musculoskeletal disorders and an aging population that is more susceptible to joint-related issues. Osteoarthritis and rheumatoid arthritis cases are on the rise, boosting the demand for effective pain management solutions like Joint Pain Injections. The growing preference for minimally invasive treatments is another key factor, as Joint Pain Injections offer relief without the need for surgery. Advances in injection therapies, such as the development of platelet-rich plasma (PRP) and hyaluronic acid injections, are enhancing the efficacy and safety of Joint Pain Injections. Sports injuries are also contributing to market growth, with athletes and active individuals seeking quick and effective pain relief. The increasing awareness of joint health and the availability of advanced healthcare facilities are supporting the adoption of Joint Pain Injections. Moreover, research and development efforts to create longer-lasting and more targeted injections are driving innovation in the field. Insurance coverage and reimbursement policies for Joint Pain Injections are also positively impacting the market. The increasing availability of non-invasive treatments and safety concerns associated with repeated injections may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Joint Pain Injections. The growth and trends of Joint Pain Injections industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Joint Pain Injections market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Joint Type

Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of Spine
Others

By Injection Type

Corticosteroid Injections
Hyaluronic Acid Injections
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Joint Pain Injections market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Joint Pain Injections market include Allergan Plc, Pfizer Inc., Sanofi, Anika Therapeutics Inc., Ferring B.V., Bioventus, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Seikagaku Corporation, Chugai Pharmaceutical Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. JOINT PAIN INJECTIONS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Joint Type
- 3.7.2 Market Attractiveness Analysis By Injection Type
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY JOINT TYPE

5.1. Overview By Joint Type
5.2. Historical and Forecast Data Analysis By Joint Type
5.3. Knee & Ankle Historic and Forecast Sales By Regions
5.4. Hip Joint Historic and Forecast Sales By Regions
5.5. Shoulder & Elbow Historic and Forecast Sales By Regions
5.6. Facet Joints of Spine Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY INJECTION TYPE

6.1. Overview By Injection Type
6.2. Historical and Forecast Data Analysis By Injection Type
6.3. Corticosteroid Injections Historic and Forecast Sales By Regions
6.4. Hyaluronic Acid Injections Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
7.4. Retail Pharmacies Historic and Forecast Sales By Regions
7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE JOINT PAIN INJECTIONS COMPANIES

9.1. Joint Pain Injections Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF JOINT PAIN INJECTIONS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Allergan Plc
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Pfizer Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sanofi
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Anika Therapeutics Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Ferring B.V.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Bioventus
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Flexion Therapeutics Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Zimmer Biomet Holdings Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Seikagaku Corporation
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Chugai Pharmaceutical Co. Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments